Ariadne Provides Pathway Studio® Interoperability with Illumina’s New GenomeStudio Software

Ariadne announces the completion of a key partner program with Illumina Inc., to provide advanced integration and interpretation capabilities for data generated from their iScan and BeadArray Reader platforms.

The coupling of Ariadne’s Pathway Studio® to Illumina’s next generation software, GenomeStudio™ Data Analysis Software, provides researchers with a toolset to analyze expression data for physiological changes, cell signaling and other significant biological changes.

“Ariadne is the first to offer a plug-in with our newly launched GenomeStudio Software program. By providing a graphical representation of Illumina’s microarray data, Pathway Studio offers researchers a unique way to complete advanced downstream analysis,” said Omoshile Clement, Ph.D., Senior Product Manager of Software Informatics at Illumina. “Illumina and its software partners continue to improve tools that aid in the interpretation of data across multiple applications.”

Pathway Studio provides academic and commercial clients with analytical capabilities for experimental data that provide biological context and mechanistic interpretation.

Proprietary algorithms analyze experimental data to perform functional analysis, identify regulated pathways, or discover new biological networks. This bench-top application provides scientists a direct method to interpret their data, to formulate new hypotheses and to design new experiments.